RxDoctor Payments Data

Haena Bryant, NP

Family · Leesburg, VANPI 1205487618

Payments from drug & device makers

$1,254in general payments, 2019–2025

Across 63 payments — averaging $19.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$174
  • Merck$154
  • Johnson & Johnson$147
  • Novo Nordisk$106
  • AstraZeneca$106
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$81
  • plus $486 from 12 others

What the payments were for

  • Food & beverage$1,254100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,254 in reported general payments places this provider in the 75th percentile of 4,332 family providers in Virginia.

See all family providers in Virginia

Medicare billing

Part B allowed, 2024
$7,189
Medicare patients
55
Services billed
87

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban170$222,332
EntrestoSacubitril/Valsartan37$68,609
XareltoRivaroxaban36$49,606
JardianceEmpagliflozin27$31,789
Repatha SureclickEvolocumab19$21,311
Praluent PenAlirocumab15$11,670
VascepaIcosapent Ethyl13$7,743
Ranolazine ErRanolazine20$2,196
Metoprolol Succinate155$2,118
Ezetimibe38$1,779
Atorvastatin Calcium175$1,726
Rosuvastatin Calcium117$1,268
Valsartan38$1,121
Losartan Potassium80$757
Amlodipine Besylate103$710

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$174$222,332170 claims
NovartisEntresto$63$68,60937 claims
Johnson & JohnsonXarelto$147$49,60636 claims
Boehringer IngelheimJardiance$73$31,78927 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,332 family providers in Virginia.

Other family in Leesburg

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →